Cargando…
Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank
BACKGROUND AND AIM: Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent or refractory Clostridioides difficile infection (rCDI). Despite inclusion in society guidelines, the uptake of FMT therapy has been variable. Physician and patient attitudes may be a barrier to ev...
Autores principales: | Gill, Madeleine, Blacketer, Charlotte, Chitti, Franco, Telfer, Karmen, Papanicolas, Lito, Dann, Lisa M, Tucker, Emily C, Bryant, Robert V, Costello, Samuel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578309/ https://www.ncbi.nlm.nih.gov/pubmed/33102769 http://dx.doi.org/10.1002/jgh3.12396 |
Ejemplares similares
-
Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
por: Chen, Justin, et al.
Publicado: (2021) -
Fecal microbiota transplantation augmented by a sulfide‐reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis
por: Bryant, Robert V, et al.
Publicado: (2021) -
Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation
por: Tucker, Emily C, et al.
Publicado: (2023) -
Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection
por: McCune, V.L., et al.
Publicado: (2020) -
Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)